The owners of a Pembroke Pines-based medical research facility pleaded guilty Monday to charges they faked information around ...

Travere Therapeutics (TVTX) has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration seeking priority review ...

The FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.

Orphan Drug Designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenström ...

National MS Education and Awareness Month is celebrated each year in the US in March, after having been launched in 2003 by ...

On January 6, 2025, the US Food and Drug Administration (FDA) and the US Department of Health and Human Services (HHS) Office for Human ...

Medical has completed the integration and design enhancements of the Apex 6 Generator into a fully integrated transvascular ...

The business conducted clinical trials of new potential drug treatments on behalf of sponsor companies seeking approval from ...

Tiziana is seeking FDA clearance for a Phase 2 clinical trial testing the safety and efficacy of its foralumab nasal spray in ...

Melanoma Companies are involved in targeted therapeutics development with respective active and inactive (dormant or ...

FILSPARI REMS: Due to the risk of hepatotoxicity and embryo-fetal toxicity, FILSPARI is available only through a restricted program called the FILSPARI REMS. Prescribers, patients, and pharmacies must ...

Promising Nonalcoholic Steatohepatitis Therapies such as AZD2693, Saroglitazar Magnesium 4 mg, Semaglutide (SEMA), Cilofexor ...